Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients ; volume:20 ; number:1 ; day:16 ; month:5 ; year:2018 ; pages:1-5 ; date:12.2018
Breast cancer research ; 20, Heft 1 (16.5.2018), 1-5, 12.2018
- Urheber
-
Allouchery, Violette
- Beteiligte Personen und Organisationen
-
Beaussire, Ludivine
Perdrix, Anne
Sefrioui, David
Augusto, Laetitia
Guillemet, Cécile
Sarafan-Vasseur, Nasrin
Di Fiore, Frédéric
Clatot, Florian
SpringerLink (Online service)
- DOI
-
10.1186/s13058-018-0968-0
- URN
-
urn:nbn:de:101:1-2018072217064638485980
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Allouchery, Violette
- Beaussire, Ludivine
- Perdrix, Anne
- Sefrioui, David
- Augusto, Laetitia
- Guillemet, Cécile
- Sarafan-Vasseur, Nasrin
- Di Fiore, Frédéric
- Clatot, Florian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Aromatase inhibitors
Aromatase inhibitors
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy
Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer
Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
Aromatase inhibitors in post-menopausal endometriosis
The Relapse
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment
Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
Aromatase inhibitors
Aromatase inhibitors
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy
Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer
Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
Aromatase inhibitors in post-menopausal endometriosis
The Relapse
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment
Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
Aromatase inhibitors
Aromatase inhibitors
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy
Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer
Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
Aromatase inhibitors in post-menopausal endometriosis
The Relapse
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment
Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients